BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148
52 results:

  • 1. Advances in MDS/AML and inositide signalling.
    De Stefano A; Marvi MV; Fazio A; McCubrey JA; Suh PG; Ratti S; Ramazzotti G; Manzoli L; Cocco L; Follo MY
    Adv Biol Regul; 2023 Jan; 87():100955. PubMed ID: 36706610
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A frequent PLCγ1 mutation in adult T-cell leukemia/lymphoma determines functional properties of the malignant cells.
    Prawiro C; Bunney TD; Kampyli C; Yaguchi H; Katan M; Bangham CRM
    Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166601. PubMed ID: 36442790
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
    Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
    Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia.
    Sha Y; Jiang R; Miao Y; Qin S; Wu W; Xia Y; Wang L; Fan L; Jin H; Xu W; Li J; Zhu H
    Front Immunol; 2022; 13():939978. PubMed ID: 36177050
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Cysteine Residue within the Kinase Domain of Zap70 Regulates Lck Activity and Proximal TCR Signaling.
    Schultz A; Schnurra M; El-Bizri A; Woessner NM; Hartmann S; Hartig R; Minguet S; Schraven B; Simeoni L
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078131
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Proteomic analysis reveals dual requirement for Grb2 and PLCγ1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation.
    Peiris MN; Meyer AN; Warda D; Campos AR; Donoghue DJ
    Oncotarget; 2022; 13():659-676. PubMed ID: 35574218
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic leukemia.
    Braun T; Stachelscheid J; Bley N; Oberbeck S; Otte M; Müller TA; Wahnschaffe L; Glaß M; Ommer K; Franitza M; Gathof B; Altmüller J; Hallek M; Auguin D; Hüttelmaier S; Schrader A; Herling M
    Cancer Res; 2022 May; 82(9):1818-1831. PubMed ID: 35259248
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation.
    Redondo Monte E; Leubolt G; Windisch R; Kerbs P; Dutta S; Landspersky T; Istvánffy R; Oostendorp RAJ; Chen-Wichmann L; Herold T; Cusan M; Schotta G; Wichmann C; Greif PA
    Exp Hematol; 2022 Apr; 108():26-35. PubMed ID: 35181392
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A computational in silico approach to predict high-risk coding and non-coding SNPs of human plcg1 gene.
    Khan SM; Faisal AM; Nila TA; Binti NN; Hosen MI; Shekhar HU
    PLoS One; 2021; 16(11):e0260054. PubMed ID: 34793541
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. plcg1 is required for AML1-ETO leukemia stem cell self-renewal.
    Schnoeder TM; Schwarzer A; Jayavelu AK; Hsu CJ; Kirkpatrick J; Döhner K; Perner F; Eifert T; Huber N; Arreba-Tutusaus P; Dolnik A; Assi SA; Nafria M; Jiang L; Dai YT; Chen Z; Chen SJ; Kellaway SG; Ptasinska A; Ng ES; Stanley EG; Elefanty AG; Buschbeck M; Bierhoff H; Brodt S; Matziolis G; Fischer KD; Hochhaus A; Chen CW; Heidenreich O; Mann M; Lane SW; Bullinger L; Ori A; von Eyss B; Bonifer C; Heidel FH
    Blood; 2022 Feb; 139(7):1080-1097. PubMed ID: 34695195
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
    Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
    Sakihama S; Morichika K; Saito R; Miyara M; Miyagi T; Hayashi M; Uchihara J; Tomoyose T; Ohshiro K; Nakayama S; Nakachi S; Morishima S; Sakai K; Nishio K; Masuzaki H; Fukushima T; Karube K
    Cancer Sci; 2021 Mar; 112(3):1300-1309. PubMed ID: 33426772
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma.
    Uchida Y; Yoshimitsu M; Hachiman M; Kusano S; Arima N; Shima K; Hayashida M; Kamada Y; Nakamura D; Arai A; Tanaka Y; Hara H; Ishitsuka K
    Eur J Haematol; 2021 Feb; 106(2):221-229. PubMed ID: 33098696
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma.
    Kataoka K; Koya J
    J Clin Exp Hematop; 2020 Sep; 60(3):66-72. PubMed ID: 32779615
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.
    Yoshida N; Shigemori K; Donaldson N; Trevisani C; Cordero NA; Stevenson KE; Bu X; Arakawa F; Takeuchi M; Ohshima K; Yoda A; Ng SY; Weinstock DM
    Blood; 2020 Apr; 135(17):1467-1471. PubMed ID: 31961925
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
    Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
    Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk).
    Tang G; Liu L; Wang X; Pan Z
    Eur J Med Chem; 2019 Jul; 173():167-183. PubMed ID: 30999237
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell leukemia/Lymphoma.
    Farmanbar A; Firouzi S; Makałowski W; Kneller R; Iwanaga M; Utsunomiya A; Nakai K; Watanabe T
    Neoplasia; 2018 Sep; 20(9):883-893. PubMed ID: 30032036
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oncogenomic analysis identifies novel biomarkers for tumor stage mycosis fungoides.
    Dong Z; Zhu X; Li Y; Gan L; Chen H; Zhang W; Sun J
    Medicine (Baltimore); 2018 May; 97(21):e10871. PubMed ID: 29794791
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetic alterations in adult T-cell leukemia/lymphoma.
    Kogure Y; Kataoka K
    Cancer Sci; 2017 Sep; 108(9):1719-1725. PubMed ID: 28627735
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.